X4 Pharmaceuticals Inc (XFOR)
4.32 -1.02 (-19.03%) 15:30 ET [NASDAQ]
4.50 x 500 4.51 x 300
Realtime by (Cboe BZX)
4.50 x 500 4.51 x 300
Realtime 5.30 -0.04 (-0.66%) 09:29 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | XFOR | ATHE | COEP | ||
| Company | X4 Pharmaceuticals Inc | Alterity Therapeutics Ltd ADR | Coeptis Therapeutics Hldgs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.33 | 3.38 | 8.68 | ||
| High | 5.50 | 3.50 | 11.17 | ||
| Low | 4.50 | 3.37 | 7.41 | ||
| Last | 4.32 | 3.49 | 9.92 | ||
| Change | -1.02 | +0.01 | +0.95 | ||
| % Change | -19.03% | +0.29% | +10.59% | ||
| Volume | 235,415 | 3,891 | 274,609 | ||
| 20-Day Average Volume | 80,330 | 17,255 | 85,055 | ||
| Previous Close | 5.34 | 3.48 | 8.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 6.08 | 3.20 | 9.82 | ||
| 20-Day Raw Stochastic | 1.37% | 93.26% | 56.57% | ||
| 20-Day Relative Strength | 29.67% | 51.83% | 49.58% | ||
| Weighted Alpha | -91.33 | -28.90 | -6.97 | ||
| Today's Opinion | 100% Sell | 40% Buy | 48% Buy | ||
| Previous Opinion | 100% Sell | 40% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.12% since 04/22/25 | +0.58% since 04/22/25 | -15.60% since 04/22/25 | ||
| Low | 4.52 on 04/29/25 | 3.30 on 04/28/25 | 6.26 on 04/25/25 | ||
| High | 6.63 on 04/28/25 | 3.56 on 04/28/25 | 12.50 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | -39.20% since 03/28/25 | +1.45% since 03/28/25 | +4.37% since 03/28/25 | ||
| Low | 4.52 on 04/29/25 | 2.52 on 04/09/25 | 6.26 on 04/25/25 | ||
| High | 7.50 on 03/31/25 | 3.56 on 04/28/25 | 12.50 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | -79.33% since 01/29/25 | +19.93% since 01/27/25 | -20.98% since 01/29/25 | ||
| Low | 4.52 on 04/29/25 | 2.52 on 04/09/25 | 6.26 on 04/25/25 | ||
| High | 24.43 on 01/30/25 | 5.87 on 01/30/25 | 13.70 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -69.45% since 10/29/24 | +202.11% since 10/29/24 | +136.47% since 10/29/24 | ||
| Low | 4.52 on 04/29/25 | 1.00 on 11/22/24 | 2.31 on 12/31/24 | ||
| High | 26.83 on 12/31/24 | 5.87 on 01/30/25 | 13.70 on 01/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,852 | 30,858 | 30,183 | ||
| Shares Outstanding, K | 5,783 | 8,867 | 3,365 | ||
| Annual Sales | 2,560,000 | 0 | 0 | ||
| Annual Net Income | -37,450,000 | -12,540,000 | -10,880,000 | ||
| Last Quarter Sales | 1,430,000 | 119,159 | 0 | ||
| Last Quarter Net Income | -39,820,000 | -1,749,580 | -3,010,000 | ||
| 60-Month Beta | 0.58 | 0.71 | -0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 03/25/25 | N/A | -1.00 on 11/13/24 | ||
| Latest Earnings Date | 05/01/25 | 10/02/20 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||